3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
venetoclax
38
Azacitidine
24
fludarabine
20
Cytarabine
18
Cyclophosphamide
16
Specimen Handling
14
blinatumomab
13
Biopsy
12
Busulfan
8
Dexamethasone
7
Melphalan
6
Daunorubicin
6
Whole-Body Irradiation
5
Vincristine
5
Thiotepa
5
Methotrexate
5
Decitabine
5
gilteritinib
4
daratumumab
4
Tacrolimus
4
Stem Cell Transplantation
4
Magnetic Resonance Spectroscopy
4
Imatinib Mesylate
4
Idarubicin
4
Exercise
4
Blood Specimen Collection
4
zanubrutinib
3
selinexor
3
ruxolitinib
3
revumenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Honey
×
Other hematologic neoplasm
×
Clear all
NCT07025824
2025-09-03
RELEVANT
Technische Universität Dresden
Phase 2
Not yet recruiting
220 enrolled